AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Quelle est la performance du prix de l'action ADDLIFE AB ?
Le prix actuel de ADDLIFE AB est de $42, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de AddLife AB (publ) ?
AddLife AB (publ) appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de AddLife AB (publ) ?
La capitalisation boursière actuelle de AddLife AB (publ) est de $4.9B
Est-ce que AddLife AB (publ) est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 5 analystes ont établi des notations d'analystes pour AddLife AB (publ), y compris 1 achat fort, 3 achat, 2 maintien, 0 vente et 1 vente forte